2m 2m 2m 2m 2m 2m 2m
CANDEL THERAPEUT (CADL)
NASDAQ
$13.09-$0.04 (-0.34%)
Price as of Aug 21, 2026 7:53 PM EDT- $1.0BMarket Cap
- 120.67%1-Year Change
- BiotechnologyIndustry
CANDEL THERAPEUT (CADL)
$13.09-$0.04 (-0.34%)
CADL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.13 | ||
Change | +$0.78 (+6.32%) | ||
Open | $12.52 | ||
High | $13.26 | ||
Low | $12.38 | ||
Previous Close | $12.35 | ||
Volume | 1,339,298 | ||
30-Day Average Volume | 1,262,858 | ||
1-Week Change | 12.03% | ||
1-Month Change | 28.47% | ||
1-Year Change | 120.67% | ||
3-Year Change | 1,072.32% | ||
5-Year Change | 108.41% | ||
Fundamentals | |||
Shares Outstanding | 76.5M | ||
Total Assets | $208.1M | ||
Market Cap | $1.0B | ||
Enterprise Value | $851.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$38.9M | ||
Free Cash Flow | -$17.3M | ||
EBIT | -$37.3M | ||
EBITDA | -$37.2M | ||
Net Working Capital | $191.5M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 8 | ||
P/E | -25 | ||
PEG | 0 | ||
Price/Free Cash Flow | -58 | ||
Price/Operating Cash Flow | -58 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue